Smiths Medical ASD, Inc.
USPTO PatentsView assignee record - 164 granted patents across 35 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Smiths ranks #2,386 of 49,997 tracked US assignees by granted-patent volume, with 164 patents across 35 technology areas.
- #2,386
- of 49,997 US assignees by volume
- Top 8%
- by Innovation Score (54.4/100)
- 13.0
- avg claims per patent
- -25%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R2386 · US Corporation #2,386 · 164 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MID 164 grants
- TOP-DECILE #2,386/49,997
- PHOTO-FINISH Nippon Soda
- CPC-FOCUS A61M · 35 areas
- INNOV-PAR 54.4/100
- CLAIMS-RICH 13.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -25% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Nippon Soda Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Smiths’s 54.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Smiths
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Landa · near
Landa · near
54 score
- Radiant Opto- · near
Radiant Opto- · near
54 score
- Smiths Medical ASD · this assignee
Smiths Medical ASD · this assignee
54 score
- Teledyne Scientific… · near
Teledyne Scientific… · near
54 score
- University OF Tsukuba · near
University OF Tsukuba · near
54 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Smiths's Innovation Score is 54.4/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Smiths?
Each dot is one of Smiths’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Smiths’s own 13.0 claims/patent is ABOVE the 12.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Smiths's grants concentrate
Smiths Medical ASD, Inc. is a focused PatentsView assignee: 35 CPC subclasses with 67.7% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2018 (35 grants) versus a trough of 11 in 2017. By volume, Smiths sits between Nippon Soda Co., Ltd. and X-Celeprint Limited.
Smiths's three-year grant acceleration
From 2019–2021 to 2022–2024, Smiths Medical ASD, Inc. moved from 39 to 47 grants (1.21x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #776. See the growth leaderboard.
Who files at Smiths's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nippon Soda
Nippon Soda Co., Ltd.
164 patents
- SII Semiconductor
SII Semiconductor Corporation
164 patents
- Smith & Nephew As…
Smith & Nephew Asia Pacific PTE. Limited
164 patents
- Solvay
Solvay SA
164 patents
- THE Board OF Trus…
THE Board OF Trustees OF THE University OF Arkansas
164 patents
- THE Japan Steel W…
THE Japan Steel Works, Ltd.
164 patents
- Univation
Univation Technologies, LLC
164 patents
- X-celeprint
X-Celeprint Limited
164 patents
- Smiths Medical ASD ◀
Smiths Medical ASD, Inc.
164 patents
What this shows Smiths holds 164 patents at rank #2,387, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Smiths
By rank, the assignees closest to #2,387 in granted patent volume.
- Nippon Soda Co., Ltd. #2,383 · 164 patents
- SII Semiconductor Corporation #2,384 · 164 patents
- Smith & Nephew Asia Pacific PTE. Limited #2,385 · 164 patents
- Solvay SA #2,386 · 164 patents
- THE Board OF Trustees OF THE University OF Arkansas #2,388 · 164 patents
- THE Japan Steel Works, Ltd. #2,389 · 164 patents
- Univation Technologies, LLC #2,390 · 164 patents
- X-Celeprint Limited #2,391 · 164 patents
Leaders in A61M (Devices FOR Introducing Media Into)
Other assignees with the most granted patents in Smiths's primary technology class.
- Becton, Dickinson and Company 1,249 in class
- Sanofi-Aventis Deutschland GMBH 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.V. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien LP 726 in class
- Terumo Kabushiki Kaisha 724 in class
- ResMed Pty Ltd 682 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Smiths, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Smiths ranks #69 of 3,490 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (54 here).
Similar claim depth
Nearest assignees by average claims per patent (13.0 here).
Smiths's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 18 | 11.0% |
| 2016 | 13 | 7.9% |
| 2017 | 11 | 6.7% |
| 2018 | 35 | 21.3% |
| 2019 | 16 | 9.8% |
| 2020 | 12 | 7.3% |
| 2021 | 11 | 6.7% |
| 2022 | 16 | 9.8% |
| 2023 | 20 | 12.2% |
| 2024 | 11 | 6.7% |
| 2025partial year | 1 | 0.6% |
Which technologies does Smiths Medical ASD, Inc. patent most?
Top 15 of 35 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Smiths Medical ASD, Inc.'s patent record in context - here's where to go next.
- Smiths Medical ASD, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 67.7% of its portfolio - see every assignee active in that class. Explore A61M
- Ranked #2,386 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Smiths Medical ASD, Inc. against Nippon Soda Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 54.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.